Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone in Hypogonadal Men with Type 2 Diabetes and Peripheral Vascular Disease
NCT00504712Phase 4Completed
- Sponsor
- Barnsley Hospital
- Start
- Feb 2006
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of testosterone in Hypogonadism and peripheral vascular disease (PVD) (2 arms), sponsored by Barnsley Hospital. Primary endpoint: Change in Arterial Stiffness at 26 weeks. Started Feb 2006; status: completed.
02
Drugs
testosterone
03
Conditions
Hypogonadismperipheral vascular disease (PVD)
Beyond the preview
Go deeper on NCT00504712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00504712.